Immunostains Laminin-5 2, Kalinin B1 and -Crystallin in the Evaluation of Malignant Spindle Cell Tumors of the Breast

被引:0
|
作者
Ross, D. S. [1 ]
D'Alfonso, T. M. [1 ]
Liu, Y-F [1 ]
Monni, S. [1 ]
Shin, S. J. [1 ]
机构
[1] Weill Cornell Med Coll, New York, NY USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
246
引用
收藏
页码:61A / 61A
页数:1
相关论文
共 50 条
  • [31] RETRACTED: A2/B1 Promotes NRF2 mRNA Stability and Inhibits Ferroptosis and Cell Proliferation in Breast Cancer Cells (Retracted Article)
    Huang, Yan
    Chen, Jingjing
    Pan, Juan
    Yang, Yifu
    Huang, Hongwu
    Lai, Huiping
    Yang, Lei
    Ai, Hongyan
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [32] Mechanism of action of a tyrphostin, 3,4-dihydroxy-α-cyanothiocinnamamide, in breast cancer cell growth inhibition involves the suppression of cyclin B1 and the functional activity of cyclin B1/p34cdc2 complex
    Carol A. Faaland
    Sreedevi Adhikarakunnathu
    Thresia Thomas
    T.J. Thomas
    Breast Cancer Research and Treatment, 1997, 44 : 47 - 56
  • [33] Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
    Inaguma, Shingo
    Wang, Zengfeng
    Lasota, Jerzy
    Onda, Masanori
    Czapiewski, Piotr
    Langfort, Renata
    Rys, Janusz
    Szpor, Joanna
    Waloszczyk, Piotr
    Okon, Krzysztof
    Biernat, Wojciech
    Ikeda, Hiroshi
    Schrump, David S.
    Hassan, Raffit
    Pastan, Ira
    Miettinen, Markku
    ONCOTARGET, 2017, 8 (16) : 26744 - 26754
  • [34] Mechanism of action of a tyrphostin, 3,4-dihydroxy-alpha-cyanothiocinnamide, in breast cancer cell growth inhibition involves the suppression of cyclin B1 and the functional activity of cyclin B1/p34(cdc2) complex
    Faaland, CA
    Adhikarakunnathu, S
    Thomas, T
    Thomas, TJ
    BREAST CANCER RESEARCH AND TREATMENT, 1997, 44 (01) : 47 - 56
  • [35] Myb family transcription factors contribute to G2/M cell cycle transition in normal and malignant hematopoietic cells by direct regulation of cyclin B1 expression.
    Nakata, Yuji
    Shetzline, Susan
    Sakashita, Chizuko
    Kalota, Anna
    Rudnick, Stephen I.
    Gewirtz, Alan M.
    BLOOD, 2006, 108 (11) : 331A - 331A
  • [36] Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA
    Gu, Wen-Jun
    Liu, Hai-Lin
    ANTI-CANCER DRUGS, 2013, 24 (06) : 566 - 576
  • [37] Direct interaction analysis of microRNA-351-5p and nuclear scaffold lamin B1 mRNA by the cell-free in vitro mRNA/miRNA binding evaluation system
    Sato, Akira
    Ogino, Yoko
    Shimotsuma, Akira
    Hiramoto, Akiko
    Kim, Hye-Sook
    Wataya, Yusuke
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2020, 39 (06): : 799 - 805
  • [38] INHIBITION OF DNA-SYNTHESIS AND GROWTH IN HUMAN BREAST STROMAL CELLS BY BRADYKININ - EVIDENCE FOR INDEPENDENT ROLES OF B1 AND B2 RECEPTORS IN THE RESPECTIVE CONTROL OF CELL-GROWTH AND PHOSPHOLIPID HYDROLYSIS
    PATEL, KV
    SCHREY, MP
    CANCER RESEARCH, 1992, 52 (02) : 334 - 340
  • [39] Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1
    Xia, Liqin
    Li, Feng
    Qiu, Jun
    Feng, Zhongming
    Xu, Zihan
    Chen, Zhengtang
    Sun, Jianguo
    BMC CANCER, 2020, 20 (01)
  • [40] Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1
    Liqin Xia
    Feng Li
    Jun Qiu
    Zhongming Feng
    Zihan Xu
    Zhengtang Chen
    Jianguo Sun
    BMC Cancer, 20